Novelion Therapeutics Inc.
-
Ticker
NVLN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Vancouver, British Columbia
Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development.
REPORT RATINGS
4.7 / 5.0 (177)
Novelion Therapeutics Inc. reports have an aggregate usefulness score of 4.7 based on 177 reviews.
Novelion Therapeutics Inc.
Most Recent Annual Report
MOST RECENT
2018 Annual Report and Form 10K
Older/Archived Annual Reports